BAIT
SRSF10
FUSIP1, FUSIP2, NSSR, PPP1R149, SFRS13, SFRS13A, SRp38, SRrp40, TASR, TASR1, TASR2, RP11-4M23.6
serine/arginine-rich splicing factor 10
GO Process (8)
GO Function (5)
GO Component (3)
Gene Ontology Biological Process
- RNA splicing, via transesterification reactions [IDA]
- cytoplasmic transport [IDA]
- mRNA export from nucleus [NAS]
- mRNA splice site selection [IDA]
- mRNA splicing, via spliceosome [IDA]
- negative regulation of mRNA splicing, via spliceosome [IDA]
- regulation of transcription, DNA-templated [NAS]
- spliceosomal tri-snRNP complex assembly [NAS]
Gene Ontology Molecular Function
Homo sapiens
PREY
HNRNPA2B1
HNRNPA2, HNRNPB1, HNRPA2, HNRPA2B1, HNRPB1, IBMPFD2, RNPA2, SNRPB1
heterogeneous nuclear ribonucleoprotein A2/B1
GO Process (5)
GO Function (4)
GO Component (6)
Gene Ontology Biological Process
Gene Ontology Molecular Function
Gene Ontology Cellular Component
Homo sapiens
Affinity Capture-MS
An interaction is inferred when a bait protein is affinity captured from cell extracts by either polyclonal antibody or epitope tag and the associated interaction partner is identified by mass spectrometric methods.
Publication
A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cells.
The elevated expression of the splicing regulator SRSF10 in metastatic colorectal cancer (CRC) stimulates the production of the pro-tumorigenic BCLAF1-L splice variant. We discovered a group of small molecules with an aminothiazole carboxamide core (GPS167, GPS192 and others) that decrease production of BCLAF1-L. While additional alternative splicing events regulated by SRSF10 are affected by GPS167/192 in HCT116 cells (e.g. in MDM4, ... [more]
NAR Cancer Jun. 01, 2021; 3(2);zcab019 [Pubmed: 34316707]
Throughput
- High Throughput
Curated By
- BioGRID